Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Diagnostic Laboratory, |
RCV001260647 | SCV001437739 | likely pathogenic | Intellectual disability | 2020-09-10 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV001270427 | SCV002604939 | likely pathogenic | Intellectual disability, autosomal dominant 6; Developmental and epileptic encephalopathy, 27 | 2022-11-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003416136 | SCV004112928 | likely pathogenic | GRIN2B-related condition | 2022-11-30 | criteria provided, single submitter | clinical testing | The GRIN2B c.1556G>A variant is predicted to result in the amino acid substitution p.Arg519Gln. This variant was reported in an individual with undefined neurodevelopmental disorder (Wang et al 2020. PubMed ID: 33004838). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating it is rare. This variant is interpreted as likely pathogenic. |
Service de Génétique Moléculaire, |
RCV001270427 | SCV001450716 | pathogenic | Intellectual disability, autosomal dominant 6; Developmental and epileptic encephalopathy, 27 | no assertion criteria provided | clinical testing |